Synapse

← npj Antimicrobials and Resistance

Papers in npj Antimicrobials and Resistance

Page 5 · newest first

  1. Rethinking the words hotspot reservoir and pristine in the environmental dimensions of antimicrobial resistancenpj Antimicrobials and Resistance · 2025
  2. Flash optimization of drug combinations for Acinetobacter baumannii with IDentif.AI-AMRnpj Antimicrobials and Resistance · 2025
  3. An Australian perspective on clinical, economic and regulatory considerations in emerging nanoparticle therapies for infectionsnpj Antimicrobials and Resistance · 2025
  4. Genomic survey of multidrug resistant Salmonella enterica serovar Minnesota clones in chicken productsnpj Antimicrobials and Resistance · 2025
  5. Genomic analysis of antimicrobial resistant Escherichia coli isolated from manure and manured agricultural grasslandsnpj Antimicrobials and Resistance · 2025
  6. Epidemiology, mechanisms, and clinical impact of bacterial heteroresistancenpj Antimicrobials and Resistance · 2025
  7. Targeting Acinetobacter baumannii resistance-nodulation-division efflux pump transcriptional regulators to combat antimicrobial resistancenpj Antimicrobials and Resistance · 2025
  8. A historical perspective on the multifunctional outer membrane channel protein TolC in Escherichia colinpj Antimicrobials and Resistance · 2025
  9. The genus Nocardia as a source of new antimicrobialsnpj Antimicrobials and Resistance · 2025
  10. Global phylogeography and genetic characterization of carbapenem and ceftazidime-avibactam resistant KPC-33-producing Pseudomonas aeruginosanpj Antimicrobials and Resistance · 2025
  11. Challenges and applications of artificial intelligence in infectious diseases and antimicrobial resistancenpj Antimicrobials and Resistance · 2025
  12. The role of gene copy number variation in antimicrobial resistance in human fungal pathogensnpj Antimicrobials and Resistance · 2025
  13. Developing a framework for tracking antimicrobial resistance gene movement in a persistent environmental reservoirnpj Antimicrobials and Resistance · 2024
  14. Antibiotic ecotoxicity and resistance risks in resource-constrained chicken and pig farming environmentsnpj Antimicrobials and Resistance · 2024
  15. Assessment of tuberculosis drug efficacy using preclinical animal models and in vitro predictive techniquesnpj Antimicrobials and Resistance · 2024
  16. Unlocking the potential of experimental evolution to study drug resistance in pathogenic funginpj Antimicrobials and Resistance · 2024
  17. Siderophores as tools and treatmentsnpj Antimicrobials and Resistance · 2024
  18. The Tol Pal system integrates maintenance of the three layered cell envelopenpj Antimicrobials and Resistance · 2024
  19. Contribution of the infection ecosystem and biogeography to antibiotic failure in vivonpj Antimicrobials and Resistance · 2024
  20. Regulation of erm(T) MLSB phenotype expression in the emergent emm92 type group A Streptococcusnpj Antimicrobials and Resistance · 2024
  21. The putative error prone polymerase REV1 mediates DNA damage and drug resistance in Candida albicansnpj Antimicrobials and Resistance · 2024
  22. Conference report of the 2024 Antimicrobial Resistance Meetingnpj Antimicrobials and Resistance · 2024
  23. Insights into durability against resistance from the antibiotic nitrofurantoinnpj Antimicrobials and Resistance · 2024
  24. Policy options for sustainable access to off-patent antibiotics in Europenpj Antimicrobials and Resistance · 2024
  25. Cpx-signalling in Yersinia pseudotuberculosis modulates Lipid-A remodelling and resistance to last-resort antimicrobialsnpj Antimicrobials and Resistance · 2024
  26. Polymicrobial infection in cystic fibrosis and future perspectives for improving Mycobacterium abscessus drug discoverynpj Antimicrobials and Resistance · 2024
  27. A one health roadmap towards understanding and mitigating emerging Fungal Antimicrobial Resistance: fAMRnpj Antimicrobials and Resistance · 2024
  28. Antibiotic susceptibility testing using minimum inhibitory concentration (MIC) assaysnpj Antimicrobials and Resistance · 2024
  29. Antibiotic resistance mediated by gene amplificationsnpj Antimicrobials and Resistance · 2024
  30. Cystic fibrosis sputum media induces an overall loss of antibiotic susceptibility in Mycobacterium abscessusnpj Antimicrobials and Resistance · 2024
  31. Changing epidemiology and antimicrobial susceptibility of bloodstream infections at a Vietnamese infectious diseases hospital (2010–2020)npj Antimicrobials and Resistance · 2024
  32. How do Gram-negative bacteria escape predation by Bdellovibrio bacteriovorus?npj Antimicrobials and Resistance · 2024
  33. Phage therapy could be key to conquering persistent bacterial lung infections in childrennpj Antimicrobials and Resistance · 2024
  34. Flumequine, a fluoroquinolone in disguisenpj Antimicrobials and Resistance · 2024
  35. Drug combinations targeting antibiotic resistancenpj Antimicrobials and Resistance · 2024
  36. Mechanisms of antimicrobial resistance in biofilmsnpj Antimicrobials and Resistance · 2024
  37. Genomic epidemiology describes introduction and outbreaks of antifungal drug-resistant Candida aurisnpj Antimicrobials and Resistance · 2024
  38. Transition metal homoeostasis is key to metabolism and drug tolerance of Mycobacterium abscessusnpj Antimicrobials and Resistance · 2024
  39. Genetic mutations in Cryptococcus neoformans pyrimidine salvage pathway enzymes contribute to reduced susceptibility against 5-fluorocytosinenpj Antimicrobials and Resistance · 2024
  40. Sinefungin, a natural nucleoside analog of S-adenosyl methionine, impairs the pathogenicity of Candida albicansnpj Antimicrobials and Resistance · 2024
  41. Stalled ribosome rescue factors exert different roles depending on types of antibiotics in Escherichia colinpj Antimicrobials and Resistance · 2024
  42. The re-emergence of sexually transmissible multidrug resistant Shigella flexneri 3a, England, United Kingdomnpj Antimicrobials and Resistance · 2024
  43. Identification and characterisation of two functional antibiotic MATE efflux pumps in the archaeon Halorubrum amylolyticumnpj Antimicrobials and Resistance · 2024
  44. The effect of antibiotic selection on collateral effects and evolvability of uropathogenic Escherichia colinpj Antimicrobials and Resistance · 2024
  45. Narrative review of recent developments and the future of penicillin allergy de-labelling by non-allergistsnpj Antimicrobials and Resistance · 2024
  46. Unveiling the critical roles of cellular metabolism suppression in antibiotic tolerancenpj Antimicrobials and Resistance · 2024
  47. Limitations of current techniques in clinical antimicrobial resistance diagnosis: examples and future prospectsnpj Antimicrobials and Resistance · 2024
  48. Modelling the impact of wastewater flows and management practices on antimicrobial resistance in dairy farmsnpj Antimicrobials and Resistance · 2024
  49. Demographic fluctuations in bloodstream Staphylococcus aureus lineages configure the mobile gene pool and antimicrobial resistancenpj Antimicrobials and Resistance · 2024
  50. Antimicrobial stewardship: a definition with a One Health perspectivenpj Antimicrobials and Resistance · 2024